Currently Viewing:
Community Oncology Alliance
Rose Gerber's Outlook on the Evolution and Goals of COA'S CPAN
July 13, 2017
Dr Barbara McAneny Discusses the Continuing Evolution of the COME HOME Model
July 07, 2017
Dr Basit Chaudhry on the Impact of the Oncology Care Model
July 05, 2017
Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects
June 30, 2017
Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives
June 23, 2017
Leah Ralph on the Political and Legal Obstacles to 340B Reform
June 20, 2017
Leah Ralph: ACCC Concerned About Potential Impact of MedPAC Proposals
May 28, 2017
Dr Daniel George on the Challenge of Cancer Vaccines
May 04, 2017
Big Data Is Advancing Cancer Care, but Interoperability Remains a Challenge
May 03, 2017
Leah Ralph on ACCC's Concerns With GOP Healthcare Reform Proposals
April 30, 2017
Linking Claims, Clinical Data Is Essential for a Learning Health System
April 28, 2017
Currently Reading
Dr Basit Chaudhry: Feedback Provides Potential Changes for the OCM
April 28, 2017
Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community
April 28, 2017
Oncology Practice Administrators Discuss Early Findings From the OCM
April 27, 2017
Rose Gerber: Cancer Patients Made Their Voices Heard on Capitol Hill
April 27, 2017
Congressman, Pharmacist, and Lawyer Debate PBMs, Drug Prices at Annual COA Meeting
April 27, 2017
Dr Barbara McAneny on Leveling the Playing Field for Community Oncology
April 27, 2017

Dr Basit Chaudhry: Feedback Provides Potential Changes for the OCM

Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.


Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.

Transcript (slightly modified)

Based on feedback from participating practices, are there changes you think should be made to the Oncology Care Model?

Yes, I think one of the areas where we’ve gotten a lot of feedback on is data reporting requirements on both the quality measures and the clinical measures. I think it’s a fundamentally important idea in measuring quality and also the clinical data, this makes sense, but I think the burden has been significant for practices.

Medicare’s tried to improve that, particularly changing the timelines for reporting requirements, but I think moving that forward would be important, particularly prioritizing which kind of data is really going to be the key to moving value-based payment forward in oncology. I think it would reduce the kind of challenges that participants are facing.

A second area would be to continue to evolve and improve the risk adjustment model and the prediction model in OCM, to make sure that’s clinically informed as possible and really reflects the complexity of the different patients that practices take care of, I think is very important.

I think a third thing we’ve heard about quite often is just complexities that are arising around model overlap between OCM and other payment models that Medicare is putting into place, particularly around MACRA and MIPS.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!